Powder: -20°C for 3 years | In solvent: -80°C for 1 year
O-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib. The formation of O-desmethyl gefitinib is dependent on the CYP2D6 activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 12,000 | |||
5 mg | 在庫あり | ¥ 26,000 | |||
10 mg | 在庫あり | ¥ 41,000 | |||
25 mg | 在庫あり | ¥ 83,000 | |||
50 mg | 在庫あり | ¥ 132,500 | |||
100 mg | 在庫あり | ¥ 189,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 28,500 |
説明 | O-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib. The formation of O-desmethyl gefitinib is dependent on the CYP2D6 activity. |
ターゲット&IC50 | EGFR:36 nM (IC50) |
分子量 | 432.88 |
分子式 | C21H22ClFN4O3 |
CAS No. | 847949-49-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (63.53 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
O-Desmethyl gefitinib 847949-49-9 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR human Gefitinib ODesmethyl gefitinib plasma inhibit HER1 CYP2D6 Epidermal growth factor receptor O Desmethyl gefitinib ErbB-1 Inhibitor inhibitor